The American Academy of Neurology and the American Heart Association have awarded the 2025 Ralph L. Sacco Scholarships for Brain Health to two researchers, Hortense Triniac, Ph.D., of Milwaukee and ...

Midlife cardiometabolic profiles were differentially associated with risk for early- and late-onset dementia regardless of genetic predisposition.

Controlled Data Anticipated June 2025 Boca Raton, Florida, April 01, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company ...

Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.

Vigil Neuroscience (VIGL) presented data highlighting its oral small molecule program, including its lead clinical candidate VG-3927, in two ...

INmune Bio (INMB) is presenting a poster at the annual International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurologic ...

Research from Kanazawa University on 8,766 older adults using MRI scans revealed a 3 percent reduction in brain white matter ...

APOE ε4 carrier status may be a genetic risk factor for vulnerability to negative anticholinergic effects. There is no clinically available laboratory test to assess anticholinergic levels.

Scientists from the University of Chicago Medicine have found that people who lose their sense of smell over time may be more ...

Increasing 24-hour sleepiness is linked to a twofold increase in dementia risk in older women compared with their peers with ...